Cart
sales@molnova.com
Sulfanitran
CAS No. 122-16-7
Sulfanitran( Sulfanitran | NSC 217299 | NSC-217299 | NSC217299 )
Catalog No. M10839 CAS No. 122-16-7
Sulfonamide or sulphonamide is the basis of several groups of drugs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 30 | In Stock |
|
| 50MG | 42 | In Stock |
|
| 100MG | 46 | In Stock |
|
| 200MG | 61 | In Stock |
|
| 500MG | 83 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSulfanitran
-
NoteResearch use only, not for human use.
-
Brief DescriptionSulfonamide or sulphonamide is the basis of several groups of drugs.
-
DescriptionSulfonamide or sulphonamide is the basis of several groups of drugs. The original antibacterial sulfonamides (sometimes called sulfa drugs or sulpha drugs) are synthetic antimicrobial agents that contain the sulfonamide group. Some sulfonamides are also devoid of antibacterial activity, e.g., the anticonvulsant sultiame. The sulfonylureas and thiazide diuretics are newer drug groups based on the antibacterial sulfonamides.
-
In Vitro——
-
In Vivo——
-
SynonymsSulfanitran | NSC 217299 | NSC-217299 | NSC217299
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorDHPS
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number122-16-7
-
Formula Weight335.34
-
Molecular FormulaC14H13N3O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCC(NC1=CC=C(S(=O)(NC2=CC=C([N+]([O-])=O)C=C2)=O)C=C1)=O
-
Chemical NameAcetamide, N-(4-(((4-nitrophenyl)amino)sulfonyl)phenyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Henry RJ, et al. Bacteriol Rev. 1943 Dec;7(4):175-262.
molnova catalog
related products
-
A-867744
A-867744 is an effective and selective type II positive allosteric modulator of the α7 nAChR (EC50: 1.0 μM).
-
Indole-3-Glyoxylyl C...
It is an organic compunds with molecular fomula C10H6ClNO2.
-
Sulfuretin
Sulfuretin is a potent anti-oxidant, has protective effect against t-BHP-induced oxidative damage in human liver-derived HepG2 cells is attributable to its ability to scavenge ROS and up-regulate the activity of HO-1 through the Nrf2/ARE and JNK/ERK signaling pathways.
